Based on PubMed | Can early-stage endometrial cancer present with vision problems, and how common is this symptom?

Early-stage endometrial cancer very rarely presents with vision problems. Most early cases cause gynecologic symptoms such as abnormal uterine bleeding, and visual symptoms are typically linked to treatment side effects or to uncommon metastatic or immune‑related phenomena in more advanced disease. ^{[1] [2]}

What is typical in early disease

• The hallmark symptoms of early endometrial cancer are gynecologic: abnormal vaginal bleeding (between periods or after menopause), and sometimes pelvic pain. ^{[2] [3]}
• Because bleeding often appears early, many endometrial cancers are diagnosed at an early stage without neurologic or eye symptoms. ^{[2] [1]}

How often are vision problems reported?

• Vision problems are not listed among common presenting symptoms in standard early‑stage endometrial cancer symptom overviews; instead, abnormal bleeding predominates. ^{[2] [1]}
• When vision problems do occur in the context of endometrial cancer, they are usually associated with:
  • Brain metastases (rare overall), which can cause headaches, weakness, seizures, confusion, balance issues, and sometimes visual disturbances. In one institutional series, 0.9% of endometrial cancer patients developed brain metastases, and visual disturbances appeared in 10% of those with brain metastases. ^[4]
  • Ocular metastasis, which is possible but reported only as isolated case reports (for example, metastasis to the iris). ^[5]
  • Paraneoplastic retinopathy (an autoimmune attack on the retina), reported in rare case reports, sometimes with small‑cell or undifferentiated histology; patients presented with decreased visual acuity and field loss. ^{[6] [7] [8]}

Taken together, these data suggest that visual symptoms at initial presentation are exceedingly uncommon, particularly in typical early-stage endometrial cancer. ^{[2] [1]}

Mechanisms behind vision problems when they occur

• Brain metastasis: A small proportion of individuals with endometrial cancer develop brain metastases months to years after diagnosis, and a subset of those may have visual symptoms depending on lesion location. ^[4]
• Ocular metastasis: Rare spread to eye structures such as the iris has been documented in case reports. ^[5]
• Paraneoplastic/autoimmune retinopathy: Rare immune‑mediated retinal injury linked to certain tumor histologies has been reported, leading to vision loss or field defects. ^{[7] [8]}
• Treatment‑related effects: In the recurrent/metastatic setting, regimens that include chemotherapy and immunotherapy (for example, carboplatin/paclitaxel with PD‑1/PD‑L1 inhibitors) can cause eye symptoms such as eye pain, redness, blurred vision, color changes, dry or watery eyes, and light sensitivity, reflecting drug‑related ocular toxicity rather than the cancer itself. ^{[9] [10] [11]}

What this means for someone with early symptoms

• If someone has early‑stage endometrial cancer, new vision problems are unlikely to be caused by the uterus tumor itself and more likely to have another explanation; however, any persistent visual change warrants prompt evaluation. ^{[2] [3]}
• In those receiving systemic therapy for recurrent or metastatic disease, eye symptoms can be treatment related and should be reported quickly because they may require eye drops, steroids, or treatment modification. ^{[9] [10]}
• In rare cases with unusual tumor types or suspected spread, clinicians may investigate paraneoplastic retinopathy or metastatic involvement when visual symptoms are otherwise unexplained. ^{[7] [4]}

Bottom line

• Vision problems are not a common presenting symptom of early endometrial cancer; abnormal uterine bleeding is the most frequent early sign. ^{[2] [1]}
• Visual symptoms in endometrial cancer are rare and, when they occur, are usually linked to brain or ocular metastases, paraneoplastic retinopathy, or treatment effects in the recurrent/metastatic context. ^{[4] [5] [7] [9]}